Aviso: Este site agrega dados públicos oficiais da FDA, ClinicalTrials.gov, PubMed e SEC EDGAR apenas para referência geral. Não constitui aconselhamento médico, diagnóstico, recomendação de tratamento ou aconselhamento de investimento.

PubMed

Navigating through regulatory frameworks for digital therapeutics and biomarkers.

PMID: 41067729 ·

C, i, n, j, a, , K, o, l, l, e, r, ;, , M, a, r, c, , B, l, a, n, c, h, a, r, d, ;, , T, h, o, m, a, s, , H, ü, g, l, e

RevistaHealth informatics journal
Ano
PMID41067729

Resumo

Background: Digital health technologies are often subject to regulatory requirements. Regulatory auditing processes are complex but necessary to guarantee quality, efficacy and safety of patients. Evolvements such as digitalized clinical trials, and digital biomarkers require a constant adaption of regulatory frameworks. Objective: This review aims to provide an overview on current regulations and standards for digital therapeutics and digital biomarkers, from technical development to market acc

Fonte oficial

Ver no PubMed →

Dados provenientes do PubMed / NCBI. Para consultar o texto integral e as informações mais recentes, recorra sempre ao registo oficial.

↑